New York · Ranked 79 of 1033 by CEO pay.
Kaleida Health
Donald Boyd, President And CEO. Fiscal year ending 2024-12.
Form 990 Part VII, columns D+E+F
Schedule H Part I line 7a
Also listed with a chief executive title in the same filings: Robert Nesselbush, Former CEO, $1,431,648. Where a chief executive retired during the year, the filing reports the final-year payout.
§1The filing
- Total revenue
- $1,948,879,909
- Total expenses
- $1,825,673,406
- Net assets
- $240,693,513
- Employees
- 10,633
- Hospitals covered
- 4 facilities across 1 filing
- Charity care, net
- $11,200,303
- Bad debt
- Medicare surplus (shortfall), as filed
- ($19,071,164)
- CEO pay from the organization (Part VII col. D)
- $3,716,363
- From related organizations (col. E)
- $0
- Other compensation, including deferred pay and nontaxable benefits (col. F)
- $47,817
- CEO total compensation (D+E+F)
- $3,764,180 to Donald Boyd
Medicare surplus (shortfall) is Schedule H Part III line 7: Medicare revenue minus the cost of Medicare care. A figure in parentheses is a shortfall. Like bad debt, it is not community benefit on the IRS form.
Source: Form 990, Kaleida Health, EIN 16-1533232, fiscal year ending 2024-12, as published by the IRS. CEO identification: ceo title.
§2Community benefit versus charity care
The rest of line 7k is Medicaid shortfall, medical education, research, subsidized services and contributions. Bad debt () and Medicare shortfall are reported separately by the IRS and are not community benefit on the form.
Every number on this page was copied from the filing linked above. If a figure is wrong, send the filing that contradicts it and the correction runs at the top of this page.
